Healthcare
Phase III trial informed by comprehensive KARDIA data set generated through three Phase II studies: KARDIA-1, KARDIA-2 and KARDIA-3 – – ...
September 02, 2025 | News
Compared with tirzepatide, Wegovy® (semaglutide) 2.4 mg showed a significant 57% greater reduction in the risk of heart atta...
September 01, 2025 | News
U.S. Food and Drug Administration (FDA) announced its approval of a subcutaneous formulation of Leqembi (lecanemab), branded as Leqembi Iql...
September 01, 2025 | News
The JungKwanJang delegation included Kim Yang-jin, Director General of the Overseas Business Division; Jung Jong, Director General of the As...
September 01, 2025 | News
Because every minute in the emergency room matters, the Chulalongkorn University Design for Society Center (CUD4S), in collaboration with the Department of...
August 29, 2025 | News
Actinogen Medical Limited (ASX: ACW) announces that a recent trial designed to confirm therapeutic blood levels of the intended commercial tablet form...
August 28, 2025 | News
Neusoft Medical Systems announced that its NeuViz P10 photon-counting CT has received market approval from China's National Medical Product...
August 28, 2025 | News
Fujitsu announced the development of a secure and efficient AI agent platform to accelerate operational efficiency and ensure stable medical service provis...
August 28, 2025 | News
Fullerton Health Pte. Ltd. ("Fullerton Health" or the "Company"), a leading healthcare solutions provider operating in nine markets across Asia-Pacifi...
August 27, 2025 | News
Otsuka Medical Devices Co., Ltd. (“Otsuka Medical Devices”) announced that the Paradise™ Ultrasound Renal Denervation (uRDN) system has r...
August 26, 2025 | News
Eligible patients can receive TTFields therapy through the Spanish National Health System Novocure announced that Spain’s Ministry of Heal...
August 26, 2025 | News
Shipments of five scanners per quarter starting on Q1’26 for total revenue of approximately $33 million over three years QT Imaging H...
August 26, 2025 | News
Groundbreaking Clinical Trial to Enroll 300 Patients in Double-Blind, Placebo-Controlled Study of Lysine-Gingipain Inhibitor Lighthouse Pharmaceuticals, a...
August 25, 2025 | News
DKSH Business Unit Healthcare has achieved a significant milestone in advancing sustainable healthcare supply chains by successfully measuring Scope 3 carb...
August 20, 2025 | News
Most Read
Bio Jobs
News
Editor Picks